NASDAQ : TLPH
Talphera, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 53.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 52.42M |
| Enterprise Value | 41.85M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 51.91M |
| Shares Outstanding | 51.91M |
| Shares Change (YoY) | +124.34% |
| Shares Change (QoQ) | +8.17% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 15.98% |
| Float | 25.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 53,462.97 |
| Forward PS | n/a |
| PB Ratio | 3.71 |
| P/TBV Ratio | 3.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 42,885.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.29 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -143.36% |
| Return on Assets (ROA) | -42.55% |
| Return on Invested Capital (ROIC) | -383.14% |
| Return on Capital Employed (ROCE) | -65.20% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | $83 |
| Profits Per Employee | -$1.26M |
| Employee Count | 12 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -16.26% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 34.59 |
| Average Volume (20 Days) | 96,916 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.07M |
| Short Previous Month | 721,534 |
| Short % of Shares Out | 2.05% |
| Short % of Float | 4.22% |
| Short Ratio (days to cover) | 7.34 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1,000 |
| Gross Profit | -6.70M |
| Operating Income | -14.75M |
| Pretax Income | -15.08M |
| Net Income | -15.08M |
| EBITDA | n/a |
| EBIT | -14.75M |
| Loss Per Share | -$0.24 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 17.08M |
| Total Debt | 6.50M |
| Net Cash | 10.58M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 14.41M |
| Book Value Per Share | 0.28 |
| Working Capital | 13.80M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -12.27M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -12.27M |
| FCF Per Share | -$0.24 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | -1,474,700.00% |
| Pretax Margin | -1,507,600.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -124.34% |
| Shareholder Yield | -124.34% |
| Earnings Yield | -23.49% |
| FCF Yield | -22.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.13 |
| Price Target Difference | 209.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 688.60% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -24.29 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |